Your Medication Information

Your Medication Information
Published: (2025)

Your Medication Information
Published: (2024)

Your Medication Information
Published: (2026)

Your Medication Information
Published: (2024)

Your Medication Information
Published: (2024)

Your Medication Information
Published: (2024)

Your Medication Information
Published: (2024)

Your Medication Information
Published: (2026)

Your Medication Information
Published: (2024)

Your Medication Information
Published: (2024)

Your Medication Information
Published: (2024)

Your Medication Information
Published: (2024)

Suicidality and psychotropic drugs: Another perspective
by: Lawrence H. Price
Published: (2025)

Liver enzyme levels elevated in healthy users of CBD products
Published: (2025)

Exposure to antipsychotics broadly disrupts glucose homeostasis
Published: (2025)

Review of GLP‐1 trials finds low incidence of suicide risk
Published: (2025)

Climate change and psychopharmacology
by: Lawrence H. Price
Published: (2025)

Review suggests need to monitor blood pressure in youths receiving ADHD medications
Published: (2025)

Study finds low correspondence between known genetic variations and treatment targets
Published: (2025)

Antidepressant discontinuation: Skepticism and science
by: Lawrence H. Price
Published: (2025)

Data on prescription stimulant misuse suggest need for closer screening
Published: (2025)

Clozapine‐associated pneumonia
by: Y. W. Francis Lam
Published: (2025)

No protective effect of omega‐3s for youths at risk of psychosis
Published: (2025)

Study generally supports telehealth for ADHD medication prescribing
Published: (2025)

Antidepressant use linked to cognitive decline in patients with dementia
Published: (2025)

Psilocybin therapy might help frontline pandemic workers
Published: (2025)

N‐acetylcysteine not more effective than placebo for co‐occurring PTSD and AUD
Published: (2025)

Solriamfetol improves symptoms in myalgic encephalomyelitis/chronic fatigue
Published: (2025)

ED visit for psychedelic use confers increased risk of psychosis
Published: (2025)

Trial finds fezolinetant efficacious for vasomotor symptoms in menopause
Published: (2025)

Depression study shows influence of patients' treatment expectancies
Published: (2025)

Fremanezumab effective for comorbid migraine and depression
Published: (2025)

Comprehensive study of GLP‐1 effects suggests neuropsychiatric benefits
Published: (2025)

Discontinuation of antipsychotics initiated in hospital improves older‐adult outcomes
Published: (2025)

Paternal exposure to valproate not linked to child neurodevelopmental disorders
Published: (2025)

The frustrating disconnect between genetics and psychopharmacology
by: Lawrence H. Price
Published: (2025)